Schedule a meeting

Care Pathways

with real evidence

Chronic Obstructive Pulmonary Disease

Pediatrics

Diabetes

Hypertension

Pre-Therapy Antineoplastic Screening

Chronic Obstructive Pulmonary Disease

Pediatrics

Diabetes

Emergency Triage Generalized Anxiety Disorder (GAD)

Generalized Anxiety Disorder Chronic Kidney Disease (CKD)

Chronic Kidney Disease Coronary Artery Disease (CAD)

Coronary Artery Disease

Pre-Consultation Anamnesis

Emergency Triage Generalized Anxiety Disorder (GAD)

Generalized Anxiety Disorder Chronic Kidney Disease (CKD)

Chronic Kidney Disease

Obesity

Post-Consultation Follow-up

Non-Alcoholic Steatohepatitis

Depression Obesity

Obesity

Post-Consultation Follow-up

Non-Alcoholic Steatohepatitis

Depression

Monitor your patients remotely and prioritize who needs it most.
Measurable results in the 1st month of implementation.

Choose a care pathway

AI agent trained to improve your clinical outcomes.

All Chronics Routine Pharma Statement of Health

Generalized Anxiety Disorder (GAD)

Goal: Assess and inform the patient about the disorder and involve them in treatment, monitor side effects, use assessment scales to measure anxiety levels during follow-up.

Ref.: American Psychiatric Association (APA) - EUA

Patient

Emergency Triage

Goal: Classify cases by severity to prioritize urgent care, use a structured method to avoid assessment errors, direct patients correctly to optimize flow and care.

Ref.: Manchester Triage Group (MTG) - UK

Patient

Coronary Artery Disease (CAD)

Goal: Control risk factors, promote treatment adherence, and prevent cardiovascular events through continuous follow-up.

Ref.: American Heart Association (AHA) - EUA

Patient

Pediatrics

Goal: Guarantee healthy growth of the child and prevent diseases, detect deficiencies early, reinforce good care practices and follow up the vaccination to reduce infant mortality.

Ref.: World Health Organization (WHO)

Patient

Pre-Therapy Antineoplastic Screening

Goal: Identify early risks, adjust doses, minimize side effects, and standardize criteria for systemic therapy.

Ref.: STAR (Systemic Therapy Assessment Routine)

Patient

PHS Light

Goal: Offer a simplified and accessible assessment, allowing for early detection of signs for intervention.

Ref.: Society of Actuaries - EUA

Proposer

Post-Consultation Follow-up

Goal: Monitor the progression of symptoms and the effectiveness of treatment, identify potential adverse reactions, reinforce recommendations to ensure understanding and adherence.

Ref.: World Health Organization (WHO)

Patient

Chronic Obstructive Pulmonary Disease (COPD)

Goal: Identify COPD in its early stages, reduce the severity of exacerbations with prevention strategies, encourage physical exercises, and cessation of smoking.

Ref.: Global Initiative for Chronic Obstructive Lung Disease (GOLD) - EUA

Patient

Obesity

Goal: Reduce the risk of diseases associated with obesity, focus on lasting habit changes, ensure continuous and multidisciplinary care.

Ref.: World Obesity Federation (WOF) - UK

Patient

Non-Alcoholic Steatohepatitis

Goal: Identify at-risk patients, classify disease severity to guide appropriate management, and implement lifestyle changes.

Ref.: American Association for the Study of Liver Diseases (AASLD) - EUA

Patient

Diabetes

Goal: Ensure proper glycemic control, monitor risk factors, and prevent chronic complications, offering continuous education to patients to encourage self-care.

Ref.: American Diabetes Association (ADA) - USA

Patient

PHS with Load

Goal: Offer a personalized assessment that considers the individual risk profile, allowing flexible adjustments in the proposal and balancing rigorous analysis with pricing adaptations.